东诚药业
(002675)
| 流通市值：91.88亿 | | | 总市值：101.92亿 |
| 流通股本：7.43亿 | | | 总股本：8.25亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 792,596,482.3 | 925,926,783.89 | 868,286,731.45 | 1,021,623,576.58 |
| 应收票据及应收账款 | 805,782,319.35 | 877,081,615.79 | 880,009,185.4 | 878,338,747.72 |
| 其中：应收票据 | 9,030,978.41 | 25,024,541.54 | 9,101,265.3 | 18,366,096 |
| 应收账款 | 796,751,340.94 | 852,057,074.25 | 870,907,920.1 | 859,972,651.72 |
| 应收款项融资 | 9,809,770.68 | 9,967,837.2 | 5,165,733.42 | 5,190,483.42 |
| 预付款项 | 33,085,604.48 | 39,629,898.62 | 41,649,482.24 | 34,061,397.86 |
| 其他应收款合计 | 17,879,280.1 | 34,088,511.59 | 63,597,852.96 | 59,193,132.19 |
| 存货 | 1,096,044,433.58 | 1,183,920,088.74 | 1,196,891,591.38 | 1,078,053,484.87 |
| 一年内到期的非流动资产 | 1,616,682.81 | 1,616,682.81 | 2,939,978.98 | 2,939,978.98 |
| 其他流动资产 | 99,425,092.98 | 105,063,644.79 | 103,473,323.61 | 85,992,804.15 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,856,239,666.28 | 3,202,585,063.43 | 3,230,853,874.6 | 3,192,720,273.08 |
| 非流动资产: | | | | |
| 债权投资 | 7,179,800 | 7,225,800 | 6,871,700 | 6,964,600 |
| 长期应收款 | 4,308,011.31 | 4,155,041.55 | 4,358,697.78 | 4,358,697.78 |
| 长期股权投资 | 66,513,477.6 | 79,840,616.3 | 79,017,999.22 | 86,616,680.24 |
| 其他权益工具投资 | 97,514,983.75 | 97,514,983.75 | 97,514,983.75 | 97,514,983.75 |
| 投资性房地产 | 96,119.13 | 96,119.13 | 96,119.13 | 96,119.13 |
| 固定资产 | 1,382,954,956.89 | 1,406,613,858.2 | 1,318,595,526.7 | 1,315,605,809 |
| 在建工程 | 719,845,831.86 | 660,662,270.58 | 693,724,910.93 | 641,374,740.53 |
| 使用权资产 | 5,626,534.97 | 6,529,157.01 | 7,629,994.4 | 6,822,583.36 |
| 无形资产 | 217,559,929.46 | 223,666,301.75 | 219,967,112.92 | 226,056,833.07 |
| 开发支出 | 182,993,568.28 | 171,952,694.51 | 101,802,992.17 | 95,911,105.84 |
| 商誉 | 2,547,028,056.22 | 2,345,736,623.72 | 2,323,927,623.14 | 2,329,645,979.67 |
| 长期待摊费用 | 36,544,814.82 | 33,376,727.01 | 36,536,291.37 | 37,330,364.13 |
| 递延所得税资产 | 60,137,991.15 | 60,196,331.17 | 66,572,504.18 | 63,708,403.87 |
| 其他非流动资产 | 104,278,253.07 | 80,806,190.35 | 77,114,913.65 | 72,238,210.36 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,432,582,328.51 | 5,178,372,715.03 | 5,033,731,369.34 | 4,984,245,110.73 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 8,288,821,994.79 | 8,380,957,778.46 | 8,264,585,243.94 | 8,176,965,383.81 |
| 流动负债: | | | | |
| 短期借款 | 420,788,322.24 | 485,623,266.68 | 459,700,814.14 | 343,819,307.2 |
| 应付票据及应付账款 | 1,004,877,154.41 | 1,203,931,532.91 | 1,284,003,845.2 | 1,331,808,113.67 |
| 其中：应付票据 | 841,156,631.41 | 1,000,517,225.73 | 1,075,131,591.04 | 1,138,332,910.63 |
| 应付账款 | 163,720,523 | 203,414,307.18 | 208,872,254.16 | 193,475,203.04 |
| 预收款项 | 22,586.99 | 25,186.99 | 27,786.99 | 30,386.99 |
| 合同负债 | 103,378,511.44 | 111,471,149.28 | 92,703,254.72 | 108,792,234.72 |
| 应付职工薪酬 | 89,394,665.9 | 84,218,734.97 | 72,642,313.05 | 97,887,040.43 |
| 应交税费 | 71,128,337.58 | 79,014,258.84 | 82,595,941.19 | 97,593,073.95 |
| 其他应付款合计 | 292,694,165.34 | 477,573,194.84 | 366,622,012.07 | 340,914,473 |
| 其中:应付利息 | 5,318,903.86 | 5,226,510.62 | 5,144,795.73 | 5,036,251.58 |
| 应付股利 | 47,047,910.69 | 190,751,583.71 | 73,142,193.39 | 73,142,193.39 |
| 一年内到期的非流动负债 | 121,813,023.05 | 90,970,365.02 | 79,298,919.53 | 51,644,057.71 |
| 其他流动负债 | 12,955,521.14 | 13,619,368.75 | 9,945,344.12 | 20,890,325.68 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,117,052,288.09 | 2,546,447,058.28 | 2,447,540,231.01 | 2,393,379,013.35 |
| 非流动负债: | | | | |
| 长期借款 | 281,873,499.74 | 138,695,123.94 | 203,546,665.34 | 232,602,294.38 |
| 租赁负债 | 6,892,478.83 | 7,239,789.44 | 8,494,712.28 | 7,530,915.46 |
| 预计负债 | 2,219,888.25 | 2,219,888.25 | 2,219,888.25 | 2,219,888.25 |
| 递延收益 | 235,013,870.62 | 236,768,224.75 | 238,522,578.37 | 240,273,448.69 |
| 递延所得税负债 | 17,966,888.08 | 17,967,539.96 | 18,295,987 | 18,614,332.29 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 543,966,625.52 | 402,890,566.34 | 471,079,831.24 | 501,240,879.07 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,661,018,913.61 | 2,949,337,624.62 | 2,918,620,062.25 | 2,894,619,892.42 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 824,595,705 | 824,595,705 | 824,595,705 | 824,595,705 |
| 资本公积 | 2,507,667,131.61 | 2,442,135,644.37 | 2,398,685,917.33 | 2,402,040,434.75 |
| 其他综合收益 | 4,106,872.08 | 2,333,945.14 | 2,381,472.73 | 4,844,629.93 |
| 盈余公积 | 217,225,236.16 | 217,225,236.16 | 217,225,236.16 | 217,225,236.16 |
| 未分配利润 | 1,462,096,161.64 | 1,360,591,034.18 | 1,350,080,617.81 | 1,299,973,976.35 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,015,691,106.49 | 4,846,881,564.85 | 4,792,968,949.03 | 4,748,679,982.19 |
| 少数股东权益 | 612,111,974.69 | 584,738,588.99 | 552,996,232.66 | 533,665,509.2 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,627,803,081.18 | 5,431,620,153.84 | 5,345,965,181.69 | 5,282,345,491.39 |
| 负债和股东权益合计 | 8,288,821,994.79 | 8,380,957,778.46 | 8,264,585,243.94 | 8,176,965,383.81 |
| 公告日期 | 2023-10-27 | 2023-08-24 | 2023-04-29 | 2023-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |